Charles Schwab Investment Management Inc Oyster Point Pharma, Inc. Transaction History

Charles Schwab Investment Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.6 - $11.2 $119,300 - $371,156	-33,139 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.58 - $17.65 $47,987 - $98,716	5,593 Added 20.3%	33,139 $386,000
Q3 2021 Nov 16, 2021	SELL	$11.67 - $18.07 $646,728 - $1 Million	-55,418 Reduced 66.8%	27,546 $327,000
Q2 2021 Aug 16, 2021	BUY	$16.25 - $21.51 $163,085 - $215,874	10,036 Added 13.76%	82,964 $1.43 Million
Q1 2021 May 17, 2021	BUY	$17.92 - $25.86 $52,272 - $75,433	2,917 Added 4.17%	72,928 $1.33 Million
Q4 2020 Feb 16, 2021	BUY	$18.13 - $25.18 $23,623 - $32,809	1,303 Added 1.9%	70,011 $1.32 Million
Q3 2020 Nov 13, 2020	BUY	$17.83 - $29.12 $960,609 - $1.57 Million	53,876 Added 363.24%	68,708 $1.45 Million
Q2 2020 Aug 14, 2020	BUY	$27.86 - $35.93 $78,927 - $101,789	2,833 Added 23.61%	14,832 $429,000
Q4 2019 Feb 07, 2020	BUY	$13.55 - $26.15 $162,586 - $313,773	11,999 New	11,999 $294,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.